Clinical observational trial for evaluation of the efficiency of different defect treatments after resection of basal cell carcinoma in face and head area

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00019812

Enrollment

1000

Registered

2021-01-21

Start date

2021-02-18

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C44

Interventions

Group 1: Single-stage defect treatment - primary wound closure post BCC resection surgery [Evaluation of clinical and demographic parameter pre-, intra- and post-surgery up to 12 months post-surgery]

Eligibility

Sex/Gender

All

Age

18 Years to 98 Years

Inclusion criteria

Inclusion criteria: Informed consent; Primary diagnosis of basal cell carcinoma or pre-treated basal cell carcinoma; Patient is able and willing to follow study related instructions

Exclusion criteria

Exclusion criteria: patients with immunosuppression; hereditary disorders (genetic dermatosis); inability to follow post-surgery instructions; inability to attend follow-up visits; inability to follow study-related instructions

Design outcomes

Primary

Measure	Time frame
Efficiency of defect treatment, evaluated via POSAS Score (VAS 1-10). Evaluation on day 10, 3 months and 12 months post-surgery.	—

Secondary

Measure	Time frame
Type of defect treatment, patients satisfaction (12 months post-surgery), rate of recurrences and secondary carcinoma (up to 12 months post-surgery), revision surgery (up to 12 months post-surgery), tumor-related data, therapy-related data, demographic data	—

Countries

Germany

Contacts

Public ContactShahram Ghanaati

Universitätsklinikum der Goethe-Universität Frankfurt am Main Klinik für Mund-, Kiefer- und Plastische Gesichtschirurgie

Study-Unit-MKPG@kgu.de+49-69-6301-4492

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026